Outcome | Cohort | Outcome descriptiona | Adjusted estimate (95% CI)b,c |
---|---|---|---|
180-day post-discharge mortality Cox proportional hazards model regression | All COVID-19 | 2.0 (31/1573) | 0.26 (0.17–0.38) |
Wild-type | 1.4 (14/989) | 0.18 (0.10–0.31) | |
Alpha | 2.7 (10/368) | 0.36 (0.19–0.68) | |
Delta | 3.1 (4/127) | 0.47 (0.17–1.27) | |
Omicron | 3.4 (3/89) | 0.39 (0.12–1.21) | |
LRTI | 9.2 (149/1613) | Reference | |
180-day hospital readmission Cox proportional hazards model regression | All COVID-19 | 21.0 (331/1573) | 0.52 (0.45–0.60) |
Wild-type | 20.0 (198/989) | 0.46 (0.39–0.55) | |
Alpha | 21.5 (79/368) | 0.53 (0.41–0.68) | |
Delta | 18.9 (24/127) | 0.42 (0.28–0.65) | |
Omicron | 33.7 (30/89) | 0.68 (0.47–0.99) | |
LRTI | 44.2 (713/1613) | Reference | |
180-day hospital readmission Fine-Gray subdistribution hazard model regression | All COVID-19 | 21.0 (331/1573) | 0.52 (0.45–0.60) |
Wild-type | 20.0 (198/989) | 0.46 (0.39–0.55) | |
Alpha | 21.5 (79/368) | 0.53 (0.41–0.69) | |
Delta | 18.9 (24/127) | 0.42 (0.27–0.66) | |
Omicron | 33.7 (30/89) | 0.68 (0.48–0.99) | |
LRTI | 44.2 (713/1613) | Reference | |
180-day days alive and at home after minus before the critical illness hospitalization Difference-in-differences analysis | All COVID-19 | − 21 [− 50, − 9] | 33.85 (29.70–38.00) |
Wild-type | − 24 [− 54, − 10] | 33.54 (29.04–38.03) | |
Alpha | − 19 [− 42, − 7] | 36.70 (30.60–42.81) | |
Delta | − 13 [− 26, − 5] | 40.44 (31.25–49.62) | |
Omicron | − 24 [− 107, − 8] | 16.07 (2.07–30.08) | |
LRTI | − 45 [− 171, − 16] | Reference |